Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

Autor: Ravandi, Farhad, Abboud, Camille N, Akard, Luke Paul, Gill, Saar I., Hsu, Jack W. *, Kambhampati, Suman *, Khan, Irum, Liu, Delong, Stock, Wendy, Brown, Janice W, Bashey, Asad, Borthakur, Gautam, DiNardo, Courtney D., Holland, H. Kent, Kadia, Tapan M., Kantarjian, Hagop M., Morris, Lawrence E, Solomon, Scott R, Mamelok, Richard David *, Panuganti, Swapna *, Van Syoc, Rod *, Wong, Alicia *, Zimmerman, Deborah *, Solh, Melhem
Zdroj: In Blood 29 November 2018 132 Supplement 1:1407-1407
Databáze: ScienceDirect